SA
Saurabh Arvind Deoghare
About Saurabh Arvind Deoghare
Data last updated:
Saurabh Arvind Deoghare is a Director at Equitas Pharmaceuticals Limited (since 2020). The company operates in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Equitas Pharmaceuticals Limited U24299MH2020PLC350156 | Director | 13 Nov 2020 | 2020 | Active |
Board colleagues of Saurabh Arvind Deoghare
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashutosh Shyamrao Sarve | 08961570 | Equitas Pharmaceuticals Limited | Director |
| Girish Damodar Kalamkar | 01911040 | Equitas Pharmaceuticals Limited | Director |
| Mangala Fadnavs | 08961572 | Equitas Pharmaceuticals Limited | Director |
| Mayuresh Dilip Katyayan | 01828789 | Equitas Pharmaceuticals Limited | Director |
| Rahul Bhagwan Trivedi | 01503324 | Equitas Pharmaceuticals Limited | Director |
| Yogesh Hemraj Patil | 05166465 | Equitas Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saurabh Arvind Deoghare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saurabh Arvind Deoghare
Saurabh Arvind Deoghare currently holds 1 directorship: Equitas Pharmaceuticals Limited (Director, since 13 Nov 2020).
Saurabh Arvind Deoghare was first appointed on 13 Nov 2020 as Director at Equitas Pharmaceuticals Limited.
The current boards of Saurabh Arvind Deoghare's companies include Ashutosh Shyamrao Sarve (Equitas Pharmaceuticals Limited), Girish Damodar Kalamkar (Equitas Pharmaceuticals Limited), Mangala Fadnavs (Equitas Pharmaceuticals Limited), Mayuresh Dilip Katyayan (Equitas Pharmaceuticals Limited), Rahul Bhagwan Trivedi (Equitas Pharmaceuticals Limited), Yogesh Hemraj Patil (Equitas Pharmaceuticals Limited).